Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Back
Evaluation ViewAttendees 169

Neonatal Clinical Trials

Neonatology
Session Type: Oral Abstract

Neonatal Clinical Trials 1

Saturday, April 26, 2025
7:00am – 8:30am HST
Location: Convention Center: Kalākaua Ballroom A (Level 4)
CE: 1.5

Disclosure(s):
Rachel G. Greenberg, MD, MB, MHS: Oak Hill Bio (Ongoing) (Products/Services: Consultant); Pediatrix Medicla Group (Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness)
John Zupancic, MD ScD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Rita M. Ryan, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Atul Malhotra, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentations:

  • 7:00am – 7:15am HST
    Targeted Oxygenation in the Respiratory Care of Preterm Infants at Delivery: Effects on Outcome (Torpido 30/60). A Randomized Controlled Clinical Trial

    Presenting Author: Julee Oei, MBBS FRACP MD (she/her/hers) – Royal Hospital for Women

  • 7:15am – 7:30am HST
    Near Infra-Red Spectroscopy Targeted Use to Reduce Adverse Outcomes in Extremely Preterm Infants (NIRTURE): A Multi-centre International Phase II Randomized Controlled Trial.

    Presenting Author: Pranav Jani, FRACP, PhD – Westmead Hospital and University of Sydney

  • 7:30am – 7:45am HST
    The DOXIE Trial (Delayed Cord Clamping with OXygen In Extremely preterm infants) A double blinded randomized controlled trial

    Presenting Author: Anup Katheria, MD – Sharp Mary Birch Hospital for Women & Newborns

  • 7:45am – 8:00am HST
    Inhaled Nitric Oxide (iNO) Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Masked Randomized Controlled Trial

    Presenting Author: Hussnain S. Mirza, MD. MBA (he/him/his) – Advent Health for Children/ UCF College of Medicine

  • 8:00am – 8:15am HST
    Aiming to Prevent Adverse Outcomes of Neonatal Hypoxic Ischemic Encephalopathy with Erythropoietin - the PAEAN Multicenter Randomized Controlled Trial

    Presenting Author: Helen G. Liley, MBChB FRACP (she/her/hers) – The University of Queensland

  • 8:15am – 8:30am HST
    Effects of IBP-9414, a Live Biotherapeutic Product on necrotizing enterocolitis, time to full enteral feeding, and mortality in very low birth weight infants: Results from the “Connection Study

    Presenting Author: Josef Neu, Doctor of Medicine (he/him/his) – University of Florida College of Medicine